UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 8-K

             Current Report Pursuant to Section 13 or 15 (d) of the
                        Securities Exchange Act of 1934


Date of report (Date of earliest event reported):  May 27, 2005


                        Bio Solutions Manufacturing, Inc.
- -------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

                                    New York
          ------------------------------------------------------------
                 (State or Other Jurisdiction of Incorporation)


            000-33229                                        16-1576984
- ------------------------------------              ------------------------------
    (Commission File Number)                      (I.R.S. Employer
                                                           Identification No.)


                    1161 James Street, Hattiesburg, MS 39401
          ------------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)


                                 (601) 582-4000
          ------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)


          ------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)



Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425

[_]  Soliciting  material  pursuant to Rule 14a-12  under the  Exchange  Act (17
     CFR240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange
     Act (17 CFR 240.14d- 2(b))

[_]  Pre-commencement  communications  pursuant  to Rule  13(e)-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))








SECTION 1- REGISTRANT'S BUSINESS AND OPERATIONS

     Not Applicable


SECTION 2 - FINANCIAL INFORMATION

     Not Applicable


SECTION 3 - SECURITIES AND TRADING MARKETS

     Not Applicable


SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL INFORMATION

     Not Applicable


SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT

Item 5.02(a) Departure of Principal Officer

     On May 25, 2004 the Company removed Michael O'Gorman as President and Chief
Executive Officer.

Item 5.02(b) Appointment of President and Chief Executive Officer

     On May 27,  2005,  the  Board of  Directors  elected  David S.  Bennett  as
President and Chief Executive Officer.

     Mr.  Bennett  has over 25 years  experience  in direct  sales  and  channel
partnerships,  including IBM, Oracle and Sun Microsystems. Most recently, he has
acted as  senior  business  development  consultant  for a number  of  specialty
start-up  firms.  He was Vice  President and Head of North American Sales for OM
Technology, Inc., a European firm. He has generated over $50 million in software
license  revenues from treasury and derivative  applications  from over 30 banks
and major financial  institutions.  From 1991 through 1997, as Head of Sales for
TCAM,  a North  American  firm  specializing  in order  management  and equities
trading,  Mr. Bennett  brought the firm into the top 5% of software firms in the
United States,  based upon both license and service bureau revenue  streams.  He
has both  graduate and post graduate  degrees in Economics  and  Education  from
Southampton University, U.K.






Item 5.02 (c) Election of a New Director

     On May 27, 2005, Robert J. Knorr, Jr. was elected to the Board of Directors
of the Company.

     Mr. Knorr has more than 40 years experience in various aspects of corporate
and international  marketing and finance.  From 1968 until 1990, he was employed
by Johnson and Johnson or its  subsidiaries  in various  positions  ranging from
cost  controller  of  a  subsidiary  to   Vice-President   of  Finance  for  the
Professional Sector of the Company.  While employed by Johnson and Johnson,  his
responsibilities  included the  installation  of a new standard  cost system and
provided the  manufacturing  departments with new and upgraded systems to better
monitor  operations,  providing  support to marketing in all aspects of finance,
coordination of financial  activities for 15 consumer and industrial  companies,
Chief Financial  Officer of a 500 million dollar consumer products company where
he directed all financial and information  technology and established major cost
improvement  programs  throughout  the  company  generating  at least 20 million
dollars per year in savings and the  negotiation of joint ventures in Russia and
served as a consultant to the Vice Chairman for the professional  sector.  Since
1990, Mr. Knorr, as a partner in Prism Consulting,  has established a consulting
company, found a new partner for Wrigley in Hungary and assisted other companies
in the development of their business plans.


SECTION 6 - [Reserved]

Not Applicable


SECTION 7 - REGULATION FD

Not Applicable


SECTION 8 - OTHER EVENTS

Not Applicable


SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS

None








                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                       Bio Solutions Manufacturing, Inc.
                                  (Registrant)


Date: June , 2005                   By: /s/ David S. Bennett
                                        ----------------------------
                                            David S. Bennett
                                            Chief Executive Officer